Search results

A global initiative, known as the Women’s Cannabis Project, has developed a new policy framework aimed at expanding access to medical cannabis for women’s health conditions across Europe, following a series of advocacy wins in the US. The framework, developed by the organisation’s European...

The Care Quality Commission has raised several concerns about patient safety and prescribing practices at a private medical cannabis clinic, following an inspection last year that identified multiple regulatory breaches. In a report published in February, regulators found failures in safe care...

A preclinical study has shed new light on why cannabis consumers may have lower body weight and a reduced risk of developing type 2 diabetes, despite its well-known tendency to increase appetite. While cannabis is commonly associated with increased food intake — often referred to as the...

A new multi-clinic patient survey has revealed findings on patients being treated with medical cannabis for anxiety, depression, and PTSD. The survey gathered responses from 6,282 patients across the clinics Mamedica, Alternaleaf, CB1 Medical, and Curaleaf. This included a 5,128-patient...

Few conditions in the field of medical cannabis are backed by such adamant patient conviction, but as little clinical data as Attention Deficit Hyperactivity Disorder (ADHD). ADHD is one of the most commonly reported reasons people seek medical cannabis prescriptions in legalised markets, yet...

The Cannabis Industry Council has published a new patient-focused guide, Travelling with Medical Cannabis, offering practical advice for UK patients navigating the complex and often inconsistent rules around travelling with prescribed medical cannabis. Whilst medical cannabis has been legal in...

The advocacy group Americans for Safe Access (ASA) has launched a new resource centre focused on organ transplantation and medical cannabis, following the death of patient Patrick Navarro, whose case has reignited concerns over discrimination in transplant eligibility. Patrick, who used...

One of the country’s largest and most widely respected polling companies, YouGov, has published the latest results of a representative survey examining the British public’s attitudes towards cannabis. While YouGov acknowledged that the survey was timed to coincide with 4/20 (April 20), the...

In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really means...

A new survey of more than 3,500 medical cannabis patients in Germany has found that more than half were able to reduce their use of other prescription medications. Data published by Bloomwell Group in its latest ‘Cannabis Barometer’ report indicates that more than half (58.9%) of patients who...

The Welsh Liberal Democrats have passed a motion designed to safeguard medical cannabis patients and protect them from discrimination. The party voted overwhelmingly to approve the motion at its spring conference in Cardiff in March, marking what some have described as a critical step forward...

Cannabis Europa, the leading B2B conference for the European cannabis industry, has announced the full programme for its 2026 London edition. Taking place at The Barbican on 26 and 27 May, the event will bring together more than 70 speakers — regulators, investors, clinicians and operators —...

Researchers found that people who consumed THC were more likely to recall words that were never shown to them and had more trouble completing everyday memory tasks, such as remembering to do something later. Published in the Journal of Psychopharmacology, the results from the double-blind...

The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis Access Programme (MCAP) following months of parliamentary pressure. Despite launching in 2021, a recent (March 18, 2026) written ministerial answer reveals that less...

A small pilot study has found preliminary evidence to suggest that the FDA-approved CBD formulation, Epidiolex, may have benefits for weight restoration and symptom improvement in anorexia patients. Anorexia Nervosa (AN) is a severe mental illness, marked by an intense fear of gaining weight...

On the second anniversary of Germany’s landmark Cannabis Act (CanG) coming into force, the most comprehensive data and analysis of its impact to date has been published. Last week, the government published the results of the second Ekocan (Evaluation des Konsumcannabisgesetzes) evaluation...

Words by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK, following what is believed to be the first time a coroner has found that a prescription for cannabis contributed to a death in...

New research suggests that long-term, heavy cannabis use is associated with subtle changes to the frontal cortex, the part of the brain involved in decision-making and executive function. The study, the findings of which were presented at the 2026 European Congress of Psychiatry this month...

By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine...

A major new systematic review has concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions and substance use disorders. This study has been covered by a significant portion of the largest mainstream media outlets both in the UK...